Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

51.91
+1.011.98%
Pre-market: 51.910.00000.00%05:48 EDT
Volume:596.63K
Turnover:30.75M
Market Cap:2.16B
PE:-16.89
High:52.10
Open:50.79
Low:49.70
Close:50.90
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 07, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 10, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Major Issues Report

8-K - Current report